Matches in SemOpenAlex for { <https://semopenalex.org/work/W4367303558> ?p ?o ?g. }
Showing items 1 to 78 of
78
with 100 items per page.
- W4367303558 abstract "<h3>Objective:</h3> We aimed to investigate whether polysomnographic (PSG) sleep parameters are associated with neuroimaging biomarkers of cerebrovascular disease in older adults. <h3>Background:</h3> White matter abnormalities are reflective of vascular contributions to cognitive impairment and dementia (VCID) in the elderly, but their relationship with sleep remains unclear. <h3>Design/Methods:</h3> From the population-based Mayo Clinic Study of Aging, we identified 140 non-demented participants who underwent at least one brain MRI and a split-night PSG. We quantified two VCID biomarkers - white matter hyperintensities (WMH) from FLAIR-MRI (n=140) and fraction anisotropy of the genu of the corpus callosum (genu FA) from diffusion MRI (n=103). For this cross-sectional analysis, we fit linear models to assess associations between diagnostic PSG parameters (N1%, N3%, mean oxyhemoglobin saturation, and log of AHI) and VCID biomarkers (log of WMH and log of genu FA), respectively, while adjusting for age (at MRI), sex, APOE4 status, composite cardiovascular and metabolic conditions (CMC) score, REM%, supine%, sleep duration (from diagnostic portion), and interval between MRI and PSG. <h3>Results:</h3> The absolute median [IQR] interval between MRI imaging and PSG was 1.74 [0.9 – 3.2] years. For every 10-point decrease in N3%, there was a 0.058 (95% CI 0.006 to 0.111, p=0.030) increase in the log of WMH and 0.006 decrease ([95% CI −0.012 to −0.0002], p=0.042) in the log of genu FA. Participants with severe sleep apnea had higher WMH burden when compared to those with mild disease, after matching for age, sex, and N3% (median [IQR] of 0.0073 [0.0044 – 0.0149] vs 0.0067 [0.0034 to 0.01], p=0.039). <h3>Conclusions:</h3> We found that reduced slow-wave sleep and severe sleep apnea were associated with higher burden of white matter abnormalities in predominantly cognitively unimpaired older adults, which contribute to greater risk of cognitive impairment, dementia, and stroke. Our study provides support for the links between sleep depth/fragmentation and intermittent hypoxia and VCID. <b>Disclosure:</b> The institution of Dr. Carvalho has received research support from NIH. Dr. McCarter has nothing to disclose. Dr. St. Louis has received publishing royalties from a publication relating to health care. Dr. St. Louis has received publishing royalties from a publication relating to health care. Scott Przybelski has nothing to disclose. Timothy Morgenthaler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Respicardia. The institution of Timothy Morgenthaler has received research support from AR Medical. Timothy Morgenthaler has received publishing royalties from a publication relating to health care. Dr. Boeve has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Rainwater Charitable Foundation. The institution of Dr. Boeve has received research support from Alector. The institution of Dr. Boeve has received research support from GE Healthcare. The institution of Dr. Boeve has received research support from Transposon. The institution of Dr. Boeve has received research support from Cognition Therapeutics. Dr. Boeve has received publishing royalties from a publication relating to health care. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Nestle. Dr. Petersen has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech, Inc.. Dr. Petersen has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche, Inc.. Dr. Petersen has received publishing royalties from a publication relating to health care. Dr. Petersen has received publishing royalties from a publication relating to health care. The institution of Dr. Jack has received research support from NIH. The institution of Dr. Jack has received research support from Alexander Family Alzheimer’s Disease Research Professorship of the Mayo Clinic. Dr. Graff-Radford has received personal compensation for serving as an employee of Mayo Clinic. Dr. Graff-Radford has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for NINDS/NIH. Dr. Graff-Radford has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Academy of Neurology. The institution of Dr. Graff-Radford has received research support from NIH. Dr. Vemuri has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Miller Medical Communications Inc.. The institution of Dr. Vemuri has received research support from NIH." @default.
- W4367303558 created "2023-04-29" @default.
- W4367303558 creator A5022096639 @default.
- W4367303558 creator A5026250910 @default.
- W4367303558 creator A5034071613 @default.
- W4367303558 creator A5043921358 @default.
- W4367303558 creator A5045246745 @default.
- W4367303558 creator A5048006717 @default.
- W4367303558 creator A5066352714 @default.
- W4367303558 creator A5074284288 @default.
- W4367303558 creator A5078384898 @default.
- W4367303558 creator A5080160824 @default.
- W4367303558 date "2023-04-25" @default.
- W4367303558 modified "2023-10-14" @default.
- W4367303558 title "Reduced Slow-Wave Sleep and Severe Sleep Apnea are Associated with Neuroimaging Biomarkers of Cerebrovascular Disease (S6.004)" @default.
- W4367303558 doi "https://doi.org/10.1212/wnl.0000000000201735" @default.
- W4367303558 hasPublicationYear "2023" @default.
- W4367303558 type Work @default.
- W4367303558 citedByCount "0" @default.
- W4367303558 crossrefType "proceedings-article" @default.
- W4367303558 hasAuthorship W4367303558A5022096639 @default.
- W4367303558 hasAuthorship W4367303558A5026250910 @default.
- W4367303558 hasAuthorship W4367303558A5034071613 @default.
- W4367303558 hasAuthorship W4367303558A5043921358 @default.
- W4367303558 hasAuthorship W4367303558A5045246745 @default.
- W4367303558 hasAuthorship W4367303558A5048006717 @default.
- W4367303558 hasAuthorship W4367303558A5066352714 @default.
- W4367303558 hasAuthorship W4367303558A5074284288 @default.
- W4367303558 hasAuthorship W4367303558A5078384898 @default.
- W4367303558 hasAuthorship W4367303558A5080160824 @default.
- W4367303558 hasConcept C118552586 @default.
- W4367303558 hasConcept C126322002 @default.
- W4367303558 hasConcept C126838900 @default.
- W4367303558 hasConcept C143409427 @default.
- W4367303558 hasConcept C146638467 @default.
- W4367303558 hasConcept C164705383 @default.
- W4367303558 hasConcept C2776006263 @default.
- W4367303558 hasConcept C2777935920 @default.
- W4367303558 hasConcept C2778205975 @default.
- W4367303558 hasConcept C2779134260 @default.
- W4367303558 hasConcept C2779483572 @default.
- W4367303558 hasConcept C2781192897 @default.
- W4367303558 hasConcept C2781326671 @default.
- W4367303558 hasConcept C58693492 @default.
- W4367303558 hasConcept C71924100 @default.
- W4367303558 hasConcept C89916169 @default.
- W4367303558 hasConceptScore W4367303558C118552586 @default.
- W4367303558 hasConceptScore W4367303558C126322002 @default.
- W4367303558 hasConceptScore W4367303558C126838900 @default.
- W4367303558 hasConceptScore W4367303558C143409427 @default.
- W4367303558 hasConceptScore W4367303558C146638467 @default.
- W4367303558 hasConceptScore W4367303558C164705383 @default.
- W4367303558 hasConceptScore W4367303558C2776006263 @default.
- W4367303558 hasConceptScore W4367303558C2777935920 @default.
- W4367303558 hasConceptScore W4367303558C2778205975 @default.
- W4367303558 hasConceptScore W4367303558C2779134260 @default.
- W4367303558 hasConceptScore W4367303558C2779483572 @default.
- W4367303558 hasConceptScore W4367303558C2781192897 @default.
- W4367303558 hasConceptScore W4367303558C2781326671 @default.
- W4367303558 hasConceptScore W4367303558C58693492 @default.
- W4367303558 hasConceptScore W4367303558C71924100 @default.
- W4367303558 hasConceptScore W4367303558C89916169 @default.
- W4367303558 hasLocation W43673035581 @default.
- W4367303558 hasOpenAccess W4367303558 @default.
- W4367303558 hasPrimaryLocation W43673035581 @default.
- W4367303558 hasRelatedWork W201255718 @default.
- W4367303558 hasRelatedWork W2106649637 @default.
- W4367303558 hasRelatedWork W2385652705 @default.
- W4367303558 hasRelatedWork W2413082403 @default.
- W4367303558 hasRelatedWork W2913949717 @default.
- W4367303558 hasRelatedWork W3034347939 @default.
- W4367303558 hasRelatedWork W3205155894 @default.
- W4367303558 hasRelatedWork W4226318805 @default.
- W4367303558 hasRelatedWork W4281754482 @default.
- W4367303558 hasRelatedWork W4319293564 @default.
- W4367303558 isParatext "false" @default.
- W4367303558 isRetracted "false" @default.
- W4367303558 workType "article" @default.